Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Telomerase reverse transcriptase mutation and the p53 pathway in T1 urinary bladder cancer.

BJU international - 1 May 2022

Jahnson Staffan, Söderkvist Peter, Aljabery Firas, Olsson Hans

Abstract excerpt

OBJECTIVE: To study the telomerase reverse transcriptase (TERT) mutation and the p53 pathway in T1 urinary bladder cancer (UBC). MATERIALS AND METHODS: This prospectively performed population-based study included all patients in the Southeast Healthcare Region in Sweden with T1 UBC registered in the period 1992-2001, inclusive. Given that p53 and TERT are important factors for tumour proliferation, although their...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Promoter Regions, Genetic
Share to Telomerase

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Tumor Suppressor Protein p53

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 34028171
DOI: 10.1111/bju.15490

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Telomerase reverse transcriptase mutation and the p53 pathway in T1 urinary bladder cancer.PMID 34028171Read ↗

Effect of co-occurring mutations in TP53 gene and TERT promoter on the survival of bladder cancer patients.Semantic proximity Read ↗

Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers.Semantic proximity Read ↗

TERT Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers.Semantic proximity Read ↗

Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis.Semantic proximity Read ↗

Emerging targets in upper tract urothelial carcinomas: the TERT gene.Semantic proximity Read ↗

Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer.Semantic proximity Read ↗

Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancerSemantic proximity Read ↗

The role of telomerase reverse transcriptase (TERT) promoter mutations in prognosis in bladder cancer.Semantic proximity Read ↗

Effect of the TERT mutation on the prognosis of patients with urothelial carcinoma: a systematic review and meta-analysis.Semantic proximity Read ↗

Small-cell Carcinomas of the Urinary Bladder and Prostate: TERT Promoter Mutation Status Differentiates Sites of Malignancy and Provides Evidence of Common Clonality Between Small-cell Carcinoma of the Urinary Bladder and Urothelial Carcinoma.Semantic proximity Read ↗

hTERT, hTR and TERT promoter mutations as markers for urological cancers detection: A systematic review.Semantic proximity Read ↗

Bladder Cancer and Genetic Mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.